Shuttle Pharmaceuticals Holdings (SHPH) Non Operating Investment Income (2023 - 2024)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Non Operating Investment Income of -$42898.0 in Q3 2024, down 53.4% quarter-over-quarter from -$27964.0 in Q2 2024, and down 546.58% on a YoY basis from $9606.0 in Q4 2023.
Shuttle Pharmaceuticals Holdings (SHPH) Non Operating Investment Income (2023 - 2024) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Non Operating Investment Income history runs 2 years deep, the most recent figure standing at -$42898.0 for Q3 2024.
- In Q3 2024, Non Operating Investment Income fell 546.58% year-over-year to -$42898.0; the TTM figure through Sep 2024 stood at -$21134.0 (changed N/A YoY), while the FY2023 annual figure was $71568.0, changed N/A from the prior year.
- Non Operating Investment Income was -$42898.0 for Q3 2024 at Shuttle Pharmaceuticals Holdings, down from -$27964.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $50434.0 in Q4 2023 to a low of -$42898.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 2.43 Mn | 1.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -42,898.00 |
| Sep 30, 2024 | -42,898.00 |
| Jun 30, 2024 | -27,964.00 |
| Jun 30, 2024 | -27,964.00 |
| Mar 31, 2024 | -706.00 |
| Mar 31, 2024 | -706.00 |
| Dec 31, 2023 | 50,434.00 |
| Dec 31, 2023 | 50,434.00 |
| Sep 30, 2023 | 9,606.00 |
| Sep 30, 2023 | 9,606.00 |
| Jun 30, 2023 | -26,534.00 |
| Jun 30, 2023 | -26,534.00 |
| Mar 31, 2023 | 38,062.00 |
| Mar 31, 2023 | 38,062.00 |